Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2026-06-30 @ 12:41 AM
Study NCT ID:
NCT02093403
Status:
COMPLETED
Last Update Posted:
2017-12-08
First Post:
2014-03-19
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Bhavana Bhatnagar
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
OSU-13182
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |